ATAI vs FOXA · rev $4.1M vs P/E 14, rev $17.13B
ATAI Life Sciences BV (ATAI) versus Fox Corp Class A (FOXA) — a side-by-side from cached financials, not a winner call.
ATAI Life Sciences BV (ATAI) is a biotechnology company listed on US.
Fox Corp Class A (FOXA) is a entertainment company listed on US.
Latest reported ATAI revenue for 2025-12-31 was $4.1M. Net income was -$660.0M. Revenue was up 1227.6% from 2024-12-31 to 2025-12-31. ATAI currently screens at market cap $555.8M.
Latest reported FOXA revenue for 2026-06-30 was $17.13B. Net income was $1.73B. Revenue was up 5.1% from 2025-06-30 to 2026-06-30. FOXA currently screens at market cap $24.50B and trailing P/E 14.1.
ATAI currently screens at market cap $555.8M. FOXA currently screens at market cap $24.50B and trailing P/E 14.1.
Not investment advice. Open the ATAI and FOXA stock pages for the full models.
Not investment advice.